Epidemiology and etiology

Childhood Leukemias, Third Edition

Volumn , Issue , 2010, Pages 49-71

  Spector, Logan G ^a   Charbonneau, Bridget ^b   Robison, Leslie L ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876444127     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511977633.004     Document Type: Chapter

References (335)

1. Horner MJ, Ries LA, Krapcho M, et al. SEER Cancer Statistics Review, 2006. Bethesda, MD: National Cancer Institute, 2009.
2. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995;75: 2186-2195.
3. Linet MS, Devesa SS. Descriptive epidemiology of childhood leukaemia. Br J Cancer 1991;63:424-429.
4. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide Version 1.0. Lyon: IARC Press, 2000.
5. Parkin DM, Kramarova ED, Draper GJ, et al. (eds.). International Incidence of Childhood Cancer, Vol II. Lyon: IARC Press, 1998.
6. Glazer ER, Perkins CI, Young JL, Jr., et al. Cancer among Hispanic children in California, 1988-1994: comparison with non-Hispanic white children. Cancer 1999;86:1070-1079.
7. Kwan ML, Buffler PA, Abrams B, Kiley VA. Breastfeeding and the risk of childhood leukemia: a meta-analysis. Public Health Rep 2004;119:521-535.
8. Bao PP, Zheng Y, Gu K, et al. Trends in childhood cancer incidence and mortality in urban Shanghai, 1973-2005. Pediatr Blood Cancer 2000;54:1009-1013.
9. Gurney JG, Davis S, Severson RK, et al.Trends in cancer incidence among children in the US. Cancer 1996;78:532-541.
10. Blair V, Birch JM. Patterns and temporal trends in the incidence of malignant disease in children: I. Leukaemia and lymphoma. Eur J Cancer 1994;30A:1490-1498.
11. McWhirter WR, Petroeschevsky AL. Incidence trends in childhood cancer in Queensland, 1973-1988. Med J Aust 1991;154:453-455.
12. Bunin GR, Feuer EJ, Witman PA, Meadows AT. Increasing incidence of childhood cancer: report of 20 years experience from the greater Delaware Valley Pediatric Tumor Registry. Paediatr Perinat Epidemiol 1996;10:319-338.
13. Kaatsch P, Haaf G, Michaelis J. Childhood malignancies in Germany: methods and results of a nationwide registry. Eur J Cancer 1995;31A:93-99.
14. Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999;91:1051-1058.
15. Taylor GM, Birch JM. he hereditary basis of human leukemia. In Henderson ES, Lister TA, Greaves MF (eds.) Leukemia. Philadelphia, PA: Saunders, 1996:210-245.
16. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ Health Perspect 1997;105:829-835.
17. Ross JA, Davies SM, Potter JD, Robison LL. Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev 1994;16:243-272.
18. Puchkova GP, Prigogina EL, Fleischmann EW, et al. Chromosome abnormalities in chronic myeloid leukemia in children. Hum Genet 1983;64:257-262.
19. Woods WG, Nesbit ME, Buckley J, et al. Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. J Clin Oncol 1985;3:3-11.
20. Cimino G, Lo-Coco F, Biondi A, et al. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993;82:544-546.
21. Pui CH, Raimondi SC, Murphy SB, et al. An analysis of leukemic cell chromosomal features in infants. Blood 1987;69:1289-1293.
22. Stone RM, Mayer RJ. he unique aspects of acute promyelocytic leukemia. J Clin Oncol 1990;8:1913-1921.
23. Secker-Walker LM, Berger R, Fenaux P, et al. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 1992;6:363-369.
24. Crist W, Carroll A, Shuster J, et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 1990;76:489-494.
25. Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995;9:1985-1989.
26. Robison LL, Neglia JP. Epidemiology of Down syndrome and childhood acute leukemia. Prog Clin Biol Res 1987;246:19-32.
27. Front C-T, Brodeur GM. Down’s syndrome and leukemia: epidemiology, genetics, cytogenetics, and the mechanisms of leukemogenesis. Cancer Genet Cytogenet 1987;28:55-76.
28. Mundschau G, Gurbuxani S, Gamis AS, et al. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood 2003;101: 4298-4300.
29. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002;32: 148-152.
30. Zipursky A, horner P, de Harven E, Christensen H, Doyle J. Myelodysplasia and acute megakaryoblastic leukemia in Down’s syndrome. Leuk Res 1994;18: 163-171.
31. Malinge S, Izraeli S, Crispino JD. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 2009;113:2619-2628.
32. Mullvihill JJ. Congenital and genetic diseases. In Fraumeni, JF, Jr. (ed.) Persons at High Risk of Cancer, San Diego, CA: Academic Press, 1975:3-31.
33. Bader JL, Miller RW. Neurofibromatosis and childhood leukemia. J Pediatr 1978;92:925-929.
34. German J, Bloom D, Passarge E. Bloom’s syndrome. VII. Progress report for 1978. Clin Genet 1979;15:361-367.
35. Woods WG, Roloff JS, Lukens JN, Krivit W. he occurrence of leukemia in patients with the Shwachman syndrome. J Pediatr 1981;99: 425-428.
36. Hecht F, Hecht BK. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet 1990;46:9-19.
37. Bloomfield CD, Brunning RD. Acute leukemia as a terminal event in nonleukemic hematopoietic disorders. Semin Oncol 1976;3:297-317.
38. Zeidler C, Reiter A, Yakisan E, et al. [Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia.] Klin Padiatr 1993;205:264-271.
39. Shannon KM, Turhan AG, Rogers PC, Kan YW. Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7. Genomics 1992;14:121-125.
40. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991;63:993-999.
41. Robison LL, Nesbit ME, Jr., Sather HN, et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group. J Pediatr 1984;105:235-242.
42. Watson MS, Carroll AJ, Shuster JJ, et al. Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602). Blood 1993;82:3098-3102.
43. Mertens AC, Wen W, Davies SM, et al. Congenital abnormalities in children with acute leukemia: a report from the Children’s Cancer Group. J Pediatr 1998;133:617-623.
44. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am JHum Genet 1997;60:474-485.
45. Anderson R. Familial leukemia. Am J Dis Child 1955;81:313-322.
46. Maklin M. Inheritance of cancer of the stomach and large intestine in man. J Natl Cancer Inst 1960;24:551-571.
47. Gunz FW, Gunz JP, Vincent PC, et al. hirteen cases of leukemia in a family. JNatl Cancer Inst 1978;60: 1243-1250.
48. Farwell J, Flannery JT. Cancer in relatives of children with central- nervous-system neoplasms. N Engl J Med 1984;311:749-753.
49. MacMahon, Levy MA. Prenatal origin of leukemia: evidence from tumors. N Engl J Med 1964;270:1082-1085.
50. Keith L, Brown ER, Ames B, Stotsky M, Keith DM. Leukemia in twins: antenatal and postnatal factors. Acta Genet Med Gemellol 1976;25:336-341.
51. Chaganti RS, Miller DR, Meyers PA, German J. Cytogenetic evidence of the intrauterine origin of acute leukemia in monozygotic twins. N Engl J Med 1979;300:1032-1034.
52. Hartley SE, Sainsbury C. Acute leukaemia and the same chromosome abnormality in monozygotic twins. Hum Genet 1981;58:408-410.
53. Strong LC. Genetics, etiology, and epidemiology of childhood cancer. In Sutow WW, Vietti TJ, Fernbach DJ (eds.) Clinical Pediatric Oncology. St. Louis, MO: Mosby, 1984:14-41.
54. Elwood PC. Possible explanation of the high concordance for acute leukemia in monozygotic twins. Lancet 1971;i:699.
55. Buckley JD, Buckley CM, Breslow NE, et al. Concordance for childhood cancer in twins. Med Pediatr Oncol 1996;26:223-229.
56. Inskip PD, Harvey EB, Boice JD, Jr., et al. Incidence of childhood cancer in twins. Cancer Cause Control 1991;2:315-24.
57. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993;363:358-360.
58. Maia AT, Ford AM, Jalali GR, et al. Molecular tracking of leukemogenesis in a triplet pregnancy Blood 2001;98: 478-482.
59. Ford AM, Pombo-de-Oliveira MS, McCarthy KP, et al. Monoclonal origin of concordant T-cell malignancy in identical twins. Blood 1997;89: 281-285.
60. Ford AM, Bennett CA, Price CM, et al. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 1998;95: 4584-4588.
61. Hawkins MM, Draper GJ, Winter DL. Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas. Br J Cancer 1995;71: 1335-1339.
62. Bajnoczky K, Khezri S, Kajtar P, et al. No chromosomal instability in offspring of survivors of childhood malignancy Cancer Genet Cytogenet 1999;109:79-80.
63. Infante-Rivard C, Guiguet M. Family history of hematopoietic and other cancers in children with acute lymphoblastic leukemia. Cancer Detect Prev 2004;28:83-87.
64. Perrillat F, Clavel J, Jaussent I, et al. Family cancer history and risk of childhood acute leukemia (France). Cancer Causes Control 2001;12: 935-941.
65. Rudant J, Menegaux F, Leverger G, et al. Family history of cancer in children with acute leukemia, Hodgkin’s lymphoma or non-Hodgkin’s lymphoma: the ESCALE study (SFCE). IntJ Cancer 2007;121:119-126.
66. Perillat-Menegaux F, Clavel J, Auclerc MF, et al. Family history of autoimmune thyroid disease and childhood acute leukemia. Cancer Epidemiol Biomarkers Prev 2003;12:60-63.
67. Snyder R. Benzene and leukemia. Crit Rev Toxicol 2002;32:155-210.
68. Stewart A. A survey of childhood malignancies. BMJ 1958;2:1495-1507.
69. MacMahon B, Newill VA. Birth characteristics of children dying of malignant neoplasms. J Natl Cancer Inst 1962;28:231-244.
70. Gibson RW, Bross ID, Graham S, et al. Leukemia in children exposed to multiple risk factors. N Engl J Med 1968;279:906-909.
71. Stewart A, Kneale GW. Radiation dose effects in relation to obstetric X-rays and childhood cancers. Lancet 1970;i:1185-1188.
72. Wakeford R. Childhood leukaemia following medical diagnostic exposure to ionizing radiation in utero or after birth. RadiatProtDosimetry 2008;132:166-174.
73. Schuz J, Ahlbom A. Exposure to electromagnetic fields and the risk of childhood leukaemia: a review. Radiat Prot Dosimetry 2008;132:202-211.
74. Linet MS, Hatch EE, Kleinerman RA, et al. Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med 1997;337: 1-7.
75. Little MP, Charles MW, Wakeford R. A review of the risks of leukemia in relation to parental pre-conception exposure to radiation. Health Phys 1995;68:299-310.
76. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. RadiatRes 1994;137: S68-S97.
77. Doll R. Hazards of ionising radiation: 100 years of observations on man. Br J Cancer 1995;72:1339-1349.
78. Harvey EB, Boice JD, Jr., Honeyman M, Flannery JT. Prenatal X-ray exposure and childhood cancer in twins. N Engl J Med 1985;312:541-545.
79. Rodvall Y, Pershagen G, Hrubec Z, et al. Prenatal X-ray exposure and childhood cancer in Swedish twins. Int J Cancer 1990;46:362-365.
80. Mole RH. Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain. Br J Cancer 1990;62:152-168.
81. Boice JD, Inskip PD. Radiation- induced leukemia. In Henderson ES, Lister TA, Greaves MF (eds.) Leukemia. Philadelphia, PA: Saunders, 1996:195-209.
82. Darby SC, Weiss HA. Human studies in radiation leukemogenesis. In Hendry JH, Lord BI (eds.) Radiation Toxicology: Bone Marrow and Leukemia. London: Taylor & Francis, 1995:337-353.
83. Simpson CI, Hempelmann LH, Fuller LM. Neoplasms in children treated with X-rays in infancy for thymic enlargement. Radiology 1955;64:840-855.
84. Ron E, Moden B. hyroid and other neoplasms following childhood scalp irradiation. In Boice JD, Fraumeni JF (eds.) Radiation Carcinogenesis, Epidemiology and Biological Significance. New York: Raven Press, 1984:139-151.
85. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin’s disease. N Engl J Med 1988;318:76-81.
86. Egeler RM, Neglia JP, Arico M, et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:81-85.
87. Infante-Rivard C, Mathonnet G, Sinnett D. Risk of childhood leukemia associated with diagnostic irradiation and polymorphisms in DNA repair genes. Environ Health Perspect 2000;108:495-498.
88. Linos A, Kyle RA, Elveback LR, Kurland LT. Leukemia in Olmsted County, Minnesota, 1965-1974. Mayo Clin Proc 1978;53:714-718.
89. Boice JD, Jr. he danger of X-rays: real or apparent? N Engl J Med 1986;315: 828-830.
90. Noshchenko AG, Bondar OY, Drozdova VD. Radiation-induced leukemia among children aged 0-5 years at the time of the Chernobyl accident. Int J Cancer 2009;127: 412-426.
91. Davis S, Day RW, Kopecky KJ, et al.Childhood leukaemia in Belarus, Russia, and Ukraine following the Chernobyl power station accident: results from an international collaborative population-based case-control study. Int J Epidemiol 2006;35:386-396.
92. Hjalmars U, Kulldorff M, Gustafsson G. Risk of acute childhood leukaemia in Sweden after the Chernobyl reactor accident. Swedish Child Leukaemia Group. BMJ 1994;309:154-157.
93. Auvinen A, Hakama M, Arvela H, et al.Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 92. BMJ 1994;309:151-154.
94. Cartwright RA, McKinney PA, Alexander FE, Ricketts J. Leukemia in young children. Lancet 1988;ii:960.
95. Gibson BE, Eden OB, Barrett A, Stiller CA, Draper GJ. Leukaemia in young children in Scotland. Lancet 1988;ii:630.
96. Michaelis J, Kaletsch U, Burkart W, Grosche B. Infant leukaemia after the Chernobyl accident. Nature 1997;387:246.
97. Torok S, Borgulya G, Lobmayer P, et al.Childhood leukaemia incidence in Hungary, 1973-2002. Interpolation model for analysing the possible effects of the Chernobyl accident. Eur J Epidemiol 2005;20:899-906.
98. Petridou E, Proukakis C, Tong D, et al. Trends and geographical distribution of childhood leukemia in Greece in relation to the Chernobyl accident. ScandJ Social Med 1994;22:127-131.
99. Petridou E, Trichopoulos D, Dessypris N, et al. Infant leukaemia after in utero exposure to radiation from Chernobyl. Nature 1996;382: 352-353.
100. Parkin DM, Cardis E, Masuyer E, et al. Childhood leukemia following the Chernobyl accident: the European Childhood Leukemia-Lymphoma Incidence Study (ECLIS). Eur J Cancer 1992;29A:87-95.
101. Ivanov EP, Tolochko G, Lazarev VS, Shuvaeva L. Child leukaemia after Chernobyl. Nature 1993;365:702.
102. UNSCEAR UNSCotEoAR. Sources and Effects of Ionizing Radiation, E.94.IX.11. New York: United Nations, 1994.
103. Stevens W, Thomas DC, Lyon JL, et al.Leukemia in Utah and radioactive fallout from the Nevada test site. A case-control study. JAMA 1990;264:585-591.
104. Cook-Mozaffari PJ, Darby SC, Doll R, et al. Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer 1989;59:476-485.
105. Bithell JF, Dutton SJ, Draper GJ, Neary NM. Distribution of childhood leukaemias and non-Hodgkin’s lymphomas near nuclear installations in England and Wales. BMJ 1994;309:501-505.
106. Hill C, Laplanche A. Overall mortality and cancer mortality around French nuclear sites. Nature 1990;347:755-757.
107. Jablon S, Hrubec Z, Boice JD, Jr. Cancer in populations living near nuclear facilities. A survey of mortality nationwide and incidence in two states. JAMA 1991;265:1403-1408.
108. Jablon S, Hrubec Z, Boice JD, Stone BJ. Cancer in Populations Living Near Nuclear Facilities. [NIH Publication 90-874.] Bethesda, MD: Public Health Service, Department of Health and Human Services, 1990.
109. Michaelis J, Keller B, Haaf G, Kaatsch P. Incidence of childhood malignancies in the vicinity of west German nuclear power plants. Cancer Causes Control 1992;3:255-263.
110. Clarke EA, McLaughlin J, Anderson TW. Childhood Leukaemia Around Canadian Nuclear Facilities: Phase II. Final Report. Ottawa, Canada: Atomic Energy Control Board, 1991.
111. COMARE CotMAoRitE. he Incidence ofCancer and Leukaemia in Young People in the Vicinity of the Sellafield Site, West Cumbria: Further Studies and an Update of the Situation since the Publication of the Report of the Black Advisory Group in 1984. London: Her Majesty’s Stationery Office, 1996.
112. Gardner MJ. Father’s occupational exposure to radiation and the raised level of childhood leukemia near the Sellafield nuclear plant. Environ Health Perspect 1991;94:5-7.
113. Shu XO, Reaman GH, Lampkin B, et al.Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Childrens Cancer Group. Cancer Epidemiol Biomarkers Prevent 1994;3:645-653.
114. McLaughlin JR, Clarke EA, Nishri ED, Anderson TW. Childhood leukemia in the vicinity of Canadian nuclear facilities. Cancer Causes Control 1993;4:51-58.
115. Parker L, Craft AW, Smith J, et al.Geographical distribution of preconceptional radiation doses to fathers employed at the Sellafield nuclear installation, West Cumbria. BMJ 1993;307:966-971.
116. Johnson KJ, Alexander BH, Doody MM, et al. Childhood cancer in the offspring born in 1921-1984 to US radiologic technologists. Br J Cancer 2008;99:545-550.
117. Little MP, Wakeford R, Kendall GM. Updated estimates of the proportion of childhood leukaemia incidence in Great Britain that may be caused by natural background ionising radiation. J Radiol Prot 2009;29:467-482.
118. Wakeford R, Kendall GM, Little MP. he risk of cancer from natural background ionizing radiation. Health Phys 2009;97:637-638 [author reply 638].
119. Henshaw DL, Eatough JP, Richardson RB. Radon as a causative factor in induction of myeloid leukaemia and other cancers. Lancet 1990;335: 1008-1012.
120. Raaschou-Nielsen O. Indoor radon and childhood leukaemia. Radiat Prot Dosimetry 2008;132:175-181.
121. Draper G. Electromagnetic fields and childhood cancer. BMJ 1993;307: 884-885.
122. Kheifets L, Oksuzyan S. Exposure assessment and other challenges in non-ionizing radiation studies of childhood leukaemia. Radiat Prot Dosimetry 2008;132:139-147.
123. Ahlbom A, Day N, Feychting M, et al. A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer 2000;83:692-698.
124. Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group. Epidemiol 2000;11:624-634.
125. Wigle DT, Turner MC, Krewski D. A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. Environ Health Perspect 2009;117:1505-1513.
126. Turner MC, Wigle DT, Krewski D. Residential pesticides and childhood leukemia: a systematic review and meta-analysis. Environ Health Perspect 2009;118:33-41.
127. Rull RP, Gunier R, Von Behren J, et al.Residential proximity to agricultural pesticide applications and childhood acute lymphoblastic leukemia. Environ Res 2009;109:891-899.
128. Lowengart RA, Peters JM, Cicioni C, et al. Childhood leukemia and parents’ occupational and home exposures. J Natl Cancer Inst 1987;79:39-46.
129. Shu XO, Stewart P, Wen WQ, et al.Parental occupational exposure to hydrocarbons and risk of acute lymphocytic leukemia in offspring. Cancer Epidemiol Biomarkers Prevent 1999;8:783-791.
130. Buckley JD, Robison LL, Swotinsky R, et al. Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Res 1989;49:4030-4037.
131. van Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, van Zanen GE. Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol 1985;14:555-559.
132. Gold EB, Diener MD, Szklo M. Parental occupations and cancer in children: a case-control study and review of the methodologic issues. J Occup Med 1982;24:578-584.
133. McKinney PA, Roberts BE, O’Brien C, et al. Chronic myeloid leukaemia in Yorkshire: a case control study. Acta Haematol 1990;83:35-38.
134. Abadi-Korek I, Stark B, Zaizov R, Shaham J. Parental occupational exposure and the risk of acute lymphoblastic leukemia in offspring in Israel. J Occup Environ Med 2006;48:165-174.
135. Infante-Rivard C, Siemiatycki J, Lakhani R, Nadon L. Maternal exposure to occupational solvents and childhood leukemia. Environ Health Perspect 2005;113:787-792.
136. McKinney PA, Raji OY, van Tongeren M, Feltbower RG. he UK Childhood Cancer Study: maternal occupational exposures and childhood leukaemia and lymphoma. Radiat Prot Dosimetry 2008;132:232-240.
137. Scelo G, Metayer C, Zhang L, et al.Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia. Environ Health Perspect 2009;117:133-139.
138. Sung TI, Wang JD, Chen PC. Increased risk of cancer in the offspring of female electronics workers. Reprod Toxicol 2008;25:115-119.
139. Shaw G, Lavey R, Jackson R, Austin D. Association of childhood leukemia with maternal age, birth order, and paternal occupation. A case-control study. Am J Epidemiol 1984;119:788-795.
140. Infante-Rivard C, Mur P, Armstrong B, Alvarez-Dardet C, Bolumar F. Acute lymphoblastic leukaemia among Spanish children and mothers’ occupation: a case-control study. J Epidemiol Community Health 1991;45:11-15.
141. Brosselin P, Rudant J, Orsi L, et al. Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE). Occup Environ Med 2009;66:598-606.
142. Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J. Risk of childhood leukemia and parental self-reported occupational exposure to chemicals, dusts, and fumes: results from pooled analyses of German population-based case-control studies. Cancer Epidemiol Biomarkers Prevent 2000;9:835-838.
143. Lyons RA, Monaghan SP, Heaven M, et al. Incidence of leukaemia and lymphoma in young people in the vicinity of the petrochemical plant at Baglan Bay, South Wales, 1974 to 1991. Occup Environ Med 1995;52: 225-228.
144. Sans S, Elliott P, Kleinschmidt I, et al.Cancer incidence and mortality near the Baglan Bay petrochemical works, South Wales. Occup Environ Med 1995;52:217-224.
145. Crosignani P, Tittarelli A, Borgini A, et al. Childhood leukemia and road traffic: a population-based case-control study. Int J Cancer 2004;108:596-599.
146. Von Behren J, Reynolds P, Gunier RB, et al. Residential traffic density and childhood leukemia risk. Cancer Epidemiol Biomarkers Prev 2008;17:2298-2301.
147. Weng HH, Tsai SS, Chen CC, et al. Childhood leukemia development and correlation with traffic air pollution in Taiwan using nitrogen dioxide as an air pollutant marker. J Toxicol Environ Health A 2008;71:434-438.
148. Pearson RL, Wachtel H, Ebi KL. Distance-weighted traffic density in proximity to a home is a risk factor for leukemia and other childhood cancers. J Air Waste Manag Assoc 2000;50: 175-180.
149. Reynolds P, Elkin E, Scalf R, Von Behren J, Neutra RR. A case-control pilot study of traffic exposures and early childhood leukemia using a geographic information system. Bioelectromagnetics 2001; Suppl 5: S58-S68.
150. Reynolds PV, von Behren J, Gunier RB, et al. Traffic patterns and childhood cancer incidence rates in California, United States. Cancer Causes Control 2002;13:665-673.
151. Alexander F, Cartwright R, McKinney PA, Ricketts TJ. Investigation of spacial clustering of rare diseases: childhood malignancies in North Humberside. J Epidemiol Community Health 1990;44:39-46.
152. Wulff M, Hogberg U, Sandstrom A. Cancer incidence for children born in a smelting community. Acta Oncol 1996;35:179-183.
153. Feychting M, Plato N, Nise G, Ahlbom A. Paternal occupational exposures and childhood cancer. Environ Health Perspect 2001;109:193-196.
154. Van Maele-Fabry G, Lantin AC, Hoet P, Lison D. Childhood leukaemia and parental occupational exposure to pesticides: a systematic review and meta-analysis. Cancer Causes Control 1989;21:787-809.
155. Robison LL, Buckley JD, Daigle AE, et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer 1989;63:1904-1911.
156. Sarasua S, Savitz DA. Cured and broiled meat consumption in relation to childhood cancer: Denver, Colorado (United States). Cancer Causes Control 1994;5:141-148.
157. Milne E, Royle JA, Miller M, et al.Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer 2001;126: 2690-2699.
158. hompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 2001;358:1935-1940.
159. Kwan ML, Jensen CD, Block G, et al.Maternal diet and risk of childhood acute lymphoblastic leukemia. Public Health Rep 2009;124:503-514.
160. Petridou E, Ntouvelis E, Dessypris N, Terzidis A, Trichopoulos D. Maternal diet and acute lymphoblastic leukemia in young children. Cancer Epidemiol Biomarkers Prev 2005;14:1935-1939.
161. Peters JM, Preston-Martin S, London SJ, et al. Processed meats and risk of childhood leukemia (California, USA). Cancer Causes Control 1994;5:195-202.
162. Liu CY, Hsu YH, Wu MT, et al. Cured meat, vegetables, and bean-curd foods in relation to childhood acute leukemia risk: a population based case-control study. BMC Cancer 2009;9:15.
163. Buckley JD, Buckley CM, Ruccione K, et al. Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. he Childrens Cancer Group. Leukemia 1994;8:856-864.
164. Kwan ML, Block G, Selvin S, Month S, Buffler PA. Food consumption by children and the risk of childhood acute leukemia. Am J Epidemiol 2004;160:1098-1107.
165. Shu XO, Gao YT, Brinton LA, et al. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988;62:635-644.
166. Severson RK, Buckley JD, Woods WG, Benjamin D, Robison LL. Cigarette smoking and alcohol consumption by parents of children with acute myeloid leukemia: an analysis within morphological subgroups: a report from the Childrens Cancer Group. Cancer Epidemiol Biomarkers Prevent 1993;2:433-439.
167. van Duijn CM, van Steensel-Moll HA, Coebergh JW, van Zanen GE. Risk factors for childhood acute non-lymphocytic leukemia: an association with maternal alcohol consumption during pregnancy? Cancer Epidemiol Biomarkers Prevent 1994;3:457-460.
168. Shu XO, Ross JA, Pendergrass TW, et al. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study. J Natl Cancer Inst 1996;88: 24-31.
169. MacArthur AC, McBride ML, Spinelli JJ, et al. Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control, 2008;19:283-295.
170. Menegaux F, Ripert M, Hemon D, Clavel J. Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French population-based case-control study. Paediatr Perinat Epidemiol 2007;21:293-299.
171. Menegaux F, Steffen C, Bellec S, et al.Maternal coffee and alcohol consumption during pregnancy, parental smoking and risk of childhood acute leukaemia. Cancer Detect Prev 2005;29:487-493.
172. Sorahan T, Lancashire R, Prior P, Peck I, Stewart A. Childhood cancer and parental use of alcohol and tobacco. Ann Epidemiol 1995;5: 354-359.
173. Stjernfeldt M, Berglund K, Lindsten J, Ludvigsson J. Maternal smoking and irradiation during pregnancy as risk factors for child leukemia. Cancer Detect Prevent 1992;16:129-135.
174. Neutel CI, Buck C. Effect of smoking during pregnancy on the risk of cancer in children. J Natl Cancer Inst 1971;47:59-63.
175. John EM, Savitz DA, Sandler DP. Prenatal exposure to parents’ smoking and childhood cancer. Am J Epidemiol 1991;133:123-132.
176. Buckley JD, Hobbie WL, Ruccione K, et al. Maternal smoking during pregnancy and the risk of childhood cancer. Lancet 1986;ii:519-520.
177. Pershagen G, Ericson A, Otterblad- Olausson P. Maternal smoking in pregnancy: does it increase the risk of childhood cancer? Int J Epidemiol 1992;21:1-5.
178. McKinney PA, Stiller C. Maternal smoking during pregnancy and the risk of childhood leukaemia. Lancet 1986; ii:519.
179. Li FP. Maternal smoking during pregnancy and the risk of childhood cancer. Lancet 1986;ii:520.
180. Ji BT, Shu XO, Linet MS, et al. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst 1997;89:238-244.
181. Rudant J, Menegaux F, Leverger G, et al. Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE). Cancer Causes Control, 2008;19:1277-1290.
182. Mucci LA, Granath F, Cnattingius S. Maternal smoking and childhood leukemia and lymphoma risk among 440 542 Swedish children. Cancer Epidemiol Biomarkers Prev 2004;13:1528-1533.
183. Sorahan T, Lancashire RJ, Hulten MA, Peck I, Stewart AM. Childhood cancer and parental use of tobacco: deaths from 1953 to 1955. Br J Cancer 1997;75:134-138.
184. Brondum J, Shu XO, Steinbuch M, et al.Parental cigarette smoking and the risk of acute leukemia in children. Cancer 1999;85:1380-1388.
185. Sandler DP, Wilcox AJ, Everson RB. Cumulative effects of lifetime passive smoking on cancer risk. Lancet 1985;i:312-315.
186. Trivers KF, Mertens AC, Ross JA, et al.Parental marijuana use and risk of childhood acute myeloid leukaemia: a report from the Children’s Cancer Group (United States and Canada). Paediatr Perinat Epidemiol 2006;20:110-118.
187. Kaye SA, Robison LL, Smithson WA, et al. Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 1991;68:1351-1355.
188. Yeazel MW, Buckley JD, Woods WG, Ruccione K, Robison LL. History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. A report from the Childrens Cancer Group. Cancer 1995;75: 1718-1727.
189. Puumala SE, Spector LG, Wall MM, et al. Infant leukemia and parental infertility or its treatment: a Children’s Oncology Group report. Hum Reprod 2010;25:1561-1568.
190. Ross JA, Potter JD, Shu XO, et al.Evaluating the relationships among maternal reproductive history, birth characteristics, and infant leukemia: a report from the Children’s Cancer Group. Ann Epidemiol 1997;7:172-179.
191. Johnson KJ, Soler JT, Puumala SE, Ross JA, Spector LG. Parental and infant characteristics and childhood leukemia in Minnesota. BMC Pediatr 2008;8:7.
192. Westergaard T, Andersen PK, Pedersen JB, et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997;89: 939-947.
193. Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ. Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol 2001;30:1428-1437.
194. Johnson KJ, Carozza SE, Chow EJ, et al.Parental age and risk of childhood cancer: a pooled analysis. Epidemiology 2009;20:475-483.
195. Zack M, Adami HO, Ericson A. Maternal and perinatal risk factors for childhood leukemia. Cancer Res 1991;51:3696-3701.
196. Hjalgrim LL, Westergaard T, Rostgaard K, et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of18 epidemiologic studies. Am J Epidemiol 2003;158:724-735.
197. Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 2009;124: 2658-2670.
198. Milne E, Royle JA, de Klerk NH, et al. Fetal growth and risk of childhood acute lymphoblastic leukemia: results from an Australian case-control study. Am J Epidemiol 2009;170: 221-228.
199. Petridou E, Skalkidou A, Dessypris N, et al. Endogenous risk factors for childhood leukemia in relation to the IGF system (Greece). he Childhood Haematologists-Oncologists Group. Cancer Causes Control 2000;11: 765-771.
200. Lei U, Wohlfahrt J, Hjalgrim H, et al.Neonatal level of thyroid-stimulating hormone and acute childhood leukemia. IntJ Cancer 2000;88: 486-488.
201. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997;94:13950-13954.
202. Pui CH, Ribeiro RC, Hancock ML, et al.Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-1687.
203. Broeker PL, Super HG, hirman MJ, et al. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase consensus binding sites. Blood 1996;87:1912-1922.
204. Wang JC. DNA topoisomerases. Annu RevBiochem 1996;65:635-692.
205. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children’s Cancer Group. Cancer Causes Control 1996;7:581-590.
206. Ross JA. Maternal diet and infant leukemia: a role for DNA topoisomerase II inhibitors? Int J Cancer 1998;11(Suppl):26-28.
207. Spector LG, Xie Y, Robison LL, et al. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the Children’s Oncology Group. Cancer Epidemiol Biomarkers Prev 2005;14:651-655.
208. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 2000;97: 4790-4795.
209. Bandele OJ, Osheroff N. Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry 2007;46:6097-6108.
210. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 2001;61: 2542-2546.
211. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994;86:1678-1680.
212. Greaves MF. Infant leukaemia biology, aetiology and treatment. Leukemia 1996;10:372-377.
213. Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer 1995;71:1-5.
214. Anderson RM, May RM. Immunisation and herd immunity. Lancet 1990;335: 641-645.
215. Boutou O, Guizard A-V, Slama R, Pottier D, Spira A. Population mixing and leukaemia in young people around the La Hague nuclear waste reprocessing plant. Br J Cancer 2002;87:740-745.
216. Langford I. Childhood leukaemia mortality and population change in England and Wales 1969-73. Social Sci Med 1991;33:435-440.
217. Stiller CA, Boyle PJ. Effect of population mixing and socioeconomic status in England and Wales, 1979-85, on lymphoblastic leukaemia in children. BMJ 1996;313:1297-1300.
218. Dickinson HO, Parker L. Quantifying the effect of population mixing on childhood leukaemia risk: the Seascale cluster. Br J Cancer 1999;81:144-151.
219. Koushik A, King WD, McLaughlin JR. An ecologic study of childhood leukemia and population mixing in Ontario, Canada. Cancer Causes Control 2001;12:483-490.
220. Dickinson HO, Hammal DM, Bithell JF, Parker L. Population mixing and childhood leukaemia and non-Hodgkin’s lymphoma in census wards in England and Wales, 1966-87. Br J Cancer 2002;86:1411-1413.
221. Parslow RC, Law GR, Feltbower R, Kinsey SE, McKinney PA. Population mixing, childhood leukaemia, CNS tumours and other childhood cancers in Yorkshire. Eur J Cancer 2002;38: 2033-2040.
222. Baccate EM. Social patterns of antibody to poliovirus. Lancet 1983;i:778-783.
223. Dworsky M, Yow M, Stagno S, Pass RF, Alford C. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983;72:295-299.
224. Parker L. Breast-feeding and cancer prevention. Eur J Cancer 2001;37: 155-158.
225. Ma X, Buffler PA, Selvin S, et al.Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2002;86: 1419-1424.
226. Perrillat F, Clavel J, Auclerc MF, et al. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer 2002;86:1064-1069.
227. Infante-Rivard C, Fortier I, Olson E. Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia. Br J Cancer 2000;83: 1559-1564.
228. Rosenbaum PF, Buck GM, Brecher ML. Early child-care and preschool experiences and the risk of childhood acute lymphoblastic leukemia. Am J Epidemiol 2000;152:1136-1144.
229. Neglia JP, Linet MS, Shu XO, et al.Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2000;82:234-240.
230. Gahrton G, Wahren B, Killander D, Foley GE. Epstein-Barr and other herpes virus antibodies in children with acute leukemia. IntJCancer 1971;8:242-249.
231. Groves FD, Sinha D, Kayhty H, Goedert JJ, Levine PH. Haemophilus influenzae type b serology in childhood leukaemia: a case-control study. Br J Cancer 2001;85:337-340.
232. Heegaard ED, Jensen L, Hornsleth A, Schmiegelow K. he role of parvovirus B19 infection in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1999;16:329-334.
233. MacKenzie J, Gallagher A, Clayton RA, et al. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia 2001;15:415-421.
234. MacKenzie J, Perry J, Ford AM, Jarrett RF, Greaves M. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia. Br J Cancer 1999;81: 898-899.
235. Salonen MJ, Siimes MA, Salonen EM, Vaheri A, Koskiniemi M. Antibody status to HHV-6 in children with leukaemia. Leukemia 2002;16: 716-719.
236. Dockerty JD, Skegg DC, Elwood JM, et al. Infections, vaccinations, and the risk of childhood leukaemia. Br J Cancer 1999;80:1483-1489.
237. McKinney PA, Juszczak E, Findlay E, Smith K, homson CS. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer 1999;80:1844-1851.
238. Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 1999;28:631-639.
239. McKinney PA, Cartwright RA, Saiu JM, et al. The inter-regional epidemiological study of childhood cancer (IRESCC): a case control study of aetiological factors in leukaemia and lymphoma. Arch Dis Child 1987;62:279-287.
240. Naumburg E, Bellocco R, Cnattingius S, Jonzon A, Ekbom A. Perinatal exposure to infection and risk of childhood leukemia. Med Pediatr Oncol 2002;38:391-397.
241. Chan LC, Lam TH, Li CK, et al. Is the timing of exposure to infection a major determinant of acute lymphoblastic leukaemia in Hong Kong? Paediatr Perinat Epidemiol 2002;16:154-165.
242. Greaves MF, Alexander FE. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 1993;7:349-360.
243. Petridou E, Kassimos D, Kalmanti M, et al. Age of exposure to infections and risk of childhood leukaemia. BMJ 1993;307:774.
244. Lomelin D, Jorgenson E, Risch N. Human genetic variation recognizes functional elements in noncoding sequence. Genome Res 2009;20: 311-319.
245. Wu M, Jolicoeur N, Li Z, et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008;29:1710-1716.
246. Dong LM, Potter JD, White E, et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008;299:2423-2436.
247. Shlien A, Malkin D. Copy number variations and cancer. Genome Med 2009;1:62.
248. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr 2000;72: 998-1003.
249. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-3295.
250. Duthie SJ, Grant G, Narayanan S. Increased uracil misincorporation in lymphocytes from folate-deficient rats. BrJ Cancer 2000;83:1532-1537.
251. Chokkalingam AP, Buffler PA. Genetic susceptibility to childhood leukaemia. Radiat Prot Dosimetry 2008; 132: 119-129.
252. Engbersen AM, Franken DG, Boers GH, et al. hermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-150.
253. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity Mol Genet Metab 1998;64:169-172.
254. Franco RF, Simoes BP, Tone LG, et al. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001;115:616-618.
255. Balta G, Yuksek N, Ozyurek E, et al.Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 2003;73:154-160.
256. Chiusolo P, Reddiconto G, Cimino G, et al. Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population. Haematologica 2004;89: 139-144.
257. Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004;103:252-257.
258. Chatzidakis K, Goulas A, Athanassiadou-Piperopoulou F, et al. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients. Pediatr Blood Cancer 2006;47:147-151.
259. Oliveira E, Alves S, Quental S, et al. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 2005;27:425-429.
260. Schnakenberg E, Mehles A, Cario G, et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 2005;6:23.
261. hirumaran RK, Gast A, Flohr T, et al. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 2005;106:2590-2591 [author reply 2591-2592].
262. Zanrosso CW, Hatagima A, Emerenciano M, et al. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk Res 2006;30:477-481.
263. Giovannetti E, Ugrasena DG, Supriyadi E, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leuk Res 2008;32:19-24.
264. Reddy H, Jamil K. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma 2006;47:1333-1339.
265. Kim NK, Chong SY, Jang MJ, et al. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res 2006;26:2879-2881.
266. Petra BG, Janez J, Vita D. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 2007;48:786-792.
267. Koppen IJ, Hermans FJ, Kaspers GJ. Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 2009;148:3-14.
268. Zintzaras E, Koufakis T, Ziakas PD, et al. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 2006;21:501-510.
269. Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1956-1963.
270. Yeoh AE, Lu Y, Chan JY, et al. Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res 2009;34:276-283.
271. Leopardi P, Marcon F, Caiola S, et al.Effects of folic acid deficiency and MTHFR C677T polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes. Mutagenesis 2006;21:327-333.
272. Milne E, de Klerk NH, van Bockxmeer F, et al. Is there a folate-related gene-environment interaction in the etiology of childhood acute lymphoblastic leukemia? Int J Cancer 2006;119:229-232.
273. Gast A, Bermejo JL, Flohr T, et al.Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 2007;21:320-325.
274. Kim HN, Kim YK, Lee IK, et al.Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk Res 2009;33:82-87.
275. Gemmati D, Ongaro A, Scapoli GL, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin’s lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004;13:787-794.
276. de Jonge R, Tissing WJ, Hooijberg JH, et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009;113:2284-2289.
277. Lightfoot TJ, Johnston WT, Painter D, et al. Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood 2004;115:3923-3929.
278. Whysner J, Reddy MV, Ross PM, Mohan M, Lax EA. Genotoxicity of benzene and its metabolites. Mutat Res 2004;566:99-130.
279. Chen H, Eastmond DA. Synergistic increase in chromosomal breakage within the euchromatin induced by an interaction of the benzene metabolites phenol and hydroquinone in mice. Carcinogenesis 1995;16: 1963-1969.
280. DeCaprio AP. he toxicology of hydroquinone: relevance to occupational and environmental exposure. Crit Rev Toxicol 1999;29:283-330.
281. Rowley JD. he critical role of chromosome translocations in human leukemias. Annu Rev Genet 1998;32:495-519.
282. Chen H, Eastmond DA. Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene’s clastogenic effects. Carcinogenesis 1995;16:2301-2307.
283. Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA 2002;99:3099-3104.
284. Beyer RE, Segura-Aguilar J, Di Bernardo S, et al. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc Natl Acad Sci USA 1996;93: 2528-2532.
285. Siegel D, Bolton EM, Burr JA, Liebler DC, Ross D. he reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherol hydroquinone as a cellular antioxidant. Mol Pharmacol 1997;52:300-305.
286. Moran JL, Siegel D, Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H: quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA 1999;96:8150-8155.
287. Clavel J, Bellec S, Rebouissou S, et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 2005;14:531-540.
288. Eguchi-Ishimae M, Eguchi M, Ishii E, et al. The association of a distinctive allele of NAD(P)H: quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica 2005;90:1511-1515.
289. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. IntJ Cancer 2002;97: 230-236.
290. Lanciotti M, Dufour C, Corral L, et al. Genetic polymorphism of NAD(P)H: quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 2005;19:214-216.
291. Sirma S, Agaoglu L, Yildiz I, et al.NAD(P)H: quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 2004;43: 568-570.
292. Kracht T, Schrappe M, Strehl S, et al. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica 2004;89:1492-1497.
293. Wiemels JL, Pagnamenta A, Taylor GM, et al. A lack of a functional NAD(P)H: quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 1999;59:4095-4099.
294. Silveira Vda S, Canalle R, Scrideli CA, Queiroz RG, Tone LG. Role of the CYP2D6, EPHX1, MPO, NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen 2008;51:48-56.
295. Guha N, Chang JS, Chokkalingam AP, et al. NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol 2008;168:1221-1232.
296. Ye Z, Song H. Glutathione S-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer 2005;41:980-989.
297. Barnette P, Scholl R, Blandford M, et al. High-throughput detection of glutathione S-transferase polymorphic alleles in a pediatric cancer population. Cancer Epidemiol Biomarkers Prev 2004;13:304-313.
298. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 2004;43:100-109.
299. Krajinovic M, Labuda D, Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 2002;12:655-658.
300. Zielinska E, Zubowska M, Bodalski J. Polymorphism within the glutathione S-transferase P1 gene is associated with increased susceptibility to childhood malignant diseases. Pediatr Blood Cancer 2004;43:552-559.
301. Gatedee J, Pakakassama S, Muangman S, Pongstaporn W. Glutathione S-transferase P1 genotypes, genetic susceptibility and outcome of therapy in hai childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev 2007;8:294-296.
302. Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 2006;81: 162-170.
303. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999;93:1496-1501.
304. Joseph T, Kusumakumary P, Chacko P, et al. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer 2004;43:560-567.
305. Pakakasama S, Mukda E, Sasanakul W, et al. Polymorphisms of drug- metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 2005;79: 202-205.
306. Krajinovic M, Richer C, Sinnett H, Labuda D, Sinnett D. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000;9: 557-562.
307. Hattori H, Suminoe A, Wada M, et al. Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia. Leuk Res 2007;31:1633-1640.
308. Jamroziak K, Mlynarski W, Balcerczak E, et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004;72:314-321.
309. Semsei AF, Erdelyi DJ, Ungvari I, et al. Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leuk Res 2008;32:1214-1220.
310. Urayama KY, Wiencke JK, Buffler PA, et al. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2007;16:1172-1177.
311. Healy J, Belanger H, Beaulieu P, et al. Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood 2007;109:683-692.
312. Wang SL, Zhao H, Zhou B, et al. Polymorphisms in ERCC1 and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Leuk Res 2006;30: 1341-1345.
313. Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 2005;217:17-24.
314. Pakakasama S, Sirirat T, Kanchanachumpol S, et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;48:16-20.
315. Batar B, Guven M, Baris S, Celkan T, Yildiz I. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2009;33: 759-763.
316. Mathonnet G, Krajinovic M, Labuda D, Sinnett D. Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia. Br J Haematol 2003; 123: 45-48.
317. Mehta PA, Alonzo TA, Gerbing RB, et al. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children’s Oncology Group report. Blood 2006;107:39-45.
318. Dearden SP, Taylor GM, Gokhale DA, et al. Molecular analysis of HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemia. Br J Cancer 1996;73:603-609.
319. Dorak MT, Owen G, Galbraith I, et al.Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia. Leukemia 1995;9:875-878.
320. Taylor GM, Dearden S, Payne N, et al. Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology Br J Cancer 1998;78:561-565.
321. Taylor GM, Dearden S, Ravetto P, et al.Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201. Hum Mol Genet 2002;11:1585-1597.
322. Taylor GM, Hussain A, Lightfoot TJ, et al. HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes. Br J Cancer 2008;98:1125-1131.
323. Taylor GM, Hussain A, Verhage V, et al.Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601. Leukemia 2009;23:863-869.
324. Santoro A, Cannella S, Trizzino A, et al.A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Haematologica 2005;90:697-698.
325. Mehta PA, Davies SM, Kumar A, et al. Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Leukemia 2006;20: 1539-1541.
326. Christensen K, Murray JC. What genome-wide association studies can do for medicine. N Engl J Med 2007;356:1094-1097.
327. Trevino LR, Yang W, French D, et al.Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009;41: 1001-1005.
328. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009;41:1006-1010.
329. Yang W, Trevino LR, Yang JJ, et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial in leukemia incidence. Leukemia 2010;24: 894-896.
330. Prasad RB, Hosking FJ, Vijayakrishnan J, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010;115:1765-1767.
331. Hosking FJ, Papaemmanuil E, Sheridan E, et al. Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia risk. Blood 2010;115:4472-4477.
332. Tasaka T, Lee S, Spira S, et al.Microsatellite instability during the progression of acute myelocytic leukaemia. Br J Haematol 1997;98:219-221.
333. Takeuchi S, Seriu T, Tasaka T, et al.Microsatellite instability and other molecular abnormalities in childhood acute lymphoblastic leukaemia. Br J Haematol 1997;98: 134-139.
334. Baccichet A, Benachenhou N, Couture F, Leclerc JM, Sinnett D. Microsatellite instability in childhood T cell acute lymphoblastic leukemia. Leukemia 1997;11:797-802.
335. Finette BA, Poseno T, Albertini RJ. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res 1996;56: 1405-1412.